Evidence map›Paper›PMID 26573585›Full record

ArticleThe Journal of experimental medicine2015

Effective effector generation of CD8+ T cells and NK cells: A need for T-bet and ZEB-too.

Sara E Hamilton, Stephen C Jameson

Abstract readComment
In one paragraph

Article in The Journal of experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. CD8Journal for immunotherapy of cancer · 2020
    Article
  3. Review
  4. Higher Numbers of T-Bet+ Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian Cancer.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2017
    Article
  5. Presentation of hepatocellular antigens.Cellular & molecular immunology · 2016
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Sara E HamiltonCenter for Immunology, University of Minnesota hamil062@umn.edu james024@umn.edu.
Stephen C JamesonCenter for Immunology, University of Minnesota hamil062@umn.edu james024@umn.edu.

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1998 to 2026
$100.4M
NCI NIH HHS P30 CA077598
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCD8-Positive T-LymphocytesCell DifferentiationHomeodomain ProteinsHumansKiller Cells, NaturalLymphocytic ChoriomeningitisMaleMelanoma, ExperimentalRepressor ProteinsT-Box Domain ProteinsT-Lymphocytes, CytotoxicT-Lymphocyte SubsetsHomeodomain ProteinsRepressor ProteinsT-Box Domain Proteins

Identifiers

PMID26573585
PMCPMC4647272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.